Matches in Nanopublications for { ?s ?p "[Furthermore, we show that amplified cancers have a high proliferative rate assessed by Ki67 staining and that FGFR1 amplification is found in 16% to 27% of luminal B-type breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP354572.RACqqFYXy4arOc6arTQz_uFS-t9gfhxdoT4kEPWL-08Eo130_assertion description "[Furthermore, we show that amplified cancers have a high proliferative rate assessed by Ki67 staining and that FGFR1 amplification is found in 16% to 27% of luminal B-type breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354572.RACqqFYXy4arOc6arTQz_uFS-t9gfhxdoT4kEPWL-08Eo130_provenance.
- NP636448.RAcTs8HiOzpi_cxbKtTCNq-FRe7Ln-SZtCuUVgtNVQuVQ130_assertion description "[Furthermore, we show that amplified cancers have a high proliferative rate assessed by Ki67 staining and that FGFR1 amplification is found in 16% to 27% of luminal B-type breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636448.RAcTs8HiOzpi_cxbKtTCNq-FRe7Ln-SZtCuUVgtNVQuVQ130_provenance.
- assertion description "[Furthermore, we show that amplified cancers have a high proliferative rate assessed by Ki67 staining and that FGFR1 amplification is found in 16% to 27% of luminal B-type breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.